Mark Smedley, global head of operations at Invitrogen, will lead the integration team that will prepare the company’s merger with Applied Biosystems. Prior to joining Invitrogen, he was with Novartis, where he led and helped with several global multi-business, multi-billion dollar integrations.
Fredrick Clerie has become vice president of quality assurance and regulatory affairs at Illumina, a new position. He reports to Joel McComb, senior vice president and general manager of Illumina's Life Sciences business unit. Prior to joining Illumina, Clerie was vice president of global quality assurance and regulatory affairs for the diagnostics division of Bayer HealthCare, now Siemens Diagnostics. Before that, he was vice president of quality assurance for the laboratory testing segment of Bayer HealthCare. Clerie holds an MS in biochemistry from the University of Illinois and a BA in biology and chemistry from Greenville College.
Louise Mawhinney has become senior vice president and chief financial officer of Ikonisys, a provider of cell-based diagnostics that is based in New Haven, Conn. She is taking over from Paul White, who continues as the company’s president. From October 2006 until March 2008, Mawhinney was senior vice president and chief financial officer of Helicos BioSciences. Prior to that, she was CFO of ArQule, Cleanwise, and The Butcher Company. Mawhinney holds an MA in Russian and moral philosophy from the University of St. Andrews in Scotland.